ARTICLE | Distillery Therapeutics
SLC12A5, Rho kinase as targets for mutation-associated intellectual disability
January 30, 2021 1:16 AM UTC
DISEASE CATEGORY: Neurology
INDICATION: Cognitive dysfunction...
BCIQ Company Profiles
DISEASE CATEGORY: Neurology
INDICATION: Cognitive dysfunction...
BCIQ Company Profiles
BCIQ Company Profiles